Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial
暂无分享,去创建一个
O. Nanni | E. Scarpi | D. Amadori | A. Biggeri | E. Petracci | S. Tamberi | F. Gelsomino | C. Accettura | G. Frassineti | A. Passardi | D. Tassinari | C. Milandri | Stefano Vecchia | I. Bernardini